Novartis – Newsemia

STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works

NewsemiaApril 2, 2020

by NewsemiaApril 2, 2020026

Rise and shine, everyone, another busy day is on the way. How could it be otherwise? Despite empty streets, the usual buzz of activity is...

Latest News

STAT Plus: FDA closes review of Novartis data integrity scandal without punishing the drug maker

NewsemiaApril 1, 2020

by NewsemiaApril 1, 2020032

An embarrassing scandal that Novartis (NVS) endured over data integrity has quietly come to a close, with the Food and Drug Administration instructing the drug...

Latest News

STAT Plus: Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal

NewsemiaMarch 31, 2020

by NewsemiaMarch 31, 2020011

Hello, everyone, and how are you coping this morning? We are doing just fine, thank you, as we continue to adjust to this new world....

Latest News

STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges

NewsemiaMarch 3, 2020

by NewsemiaMarch 3, 2020027

In the latest fallout from a federal probe into generic drug price fixing, the Sandoz unit of Novartis (NVS) agreed to pay $195 million to...

Latest News

STAT Plus: Novartis employee claims she was fired for complaining about incorrect data

NewsemiaFebruary 29, 2020

by NewsemiaFebruary 29, 202003

As Novartis (NVS) geared up to win approval for a new eye medication that was pegged to become a blockbuster, an employee tried to push...

Latest News

STAT Plus: Safety concerns regarding Novartis’ new eye drug boost Regeneron stock

NewsemiaFebruary 24, 2020

by NewsemiaFebruary 24, 2020033

A leading association of eye doctors has warned its members about safety concerns about Novartis’ new eye drug, sending the company’s stock down sharply Monday...

Latest News

STAT Plus: Pharmalittle: Novartis lottery for gene therapy begins amid tough questions; coronavirus vaccine may take a year

NewsemiaFebruary 8, 2020

by NewsemiaFebruary 8, 2020042

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal...

Latest News

STAT Plus: U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment

NewsemiaJanuary 31, 2020

by NewsemiaJanuary 31, 2020025

In an unexpected move, the U.S. Department of Health and Human Services will allow Novartis (NVS) to pay for travel, lodging, and meal expenses for...

Latest News

STAT Plus: Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020030

Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue? Consider the alternatives, after all....

Latest News

Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020024

Zolgensma, the Novartis gene therapy for infants and the world’s most expensive medicine, continues to perform well commercially, bringing in $186 million during the fourth...

Latest News

Iron Deficiency Anemia, Pipeline Review, H1 2020 – Akebia Therapeutics Inc, Novartis AG & Rockwell Medical Inc – ResearchAndMarkets.com

NewsemiaJanuary 29, 2020

by NewsemiaJanuary 29, 2020025

DUBLIN–(BUSINESS WIRE)–The “Iron Deficiency Anemia – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Iron Deficiency Anemia – Pipeline Review, H1...

Pharma / Biotech

STALEVO (carbidopa, levodopa, and entacapone) tablet, film coated [Novartis Pharmaceuticals Corporation]

NewsemiaJanuary 15, 2020

by NewsemiaJanuary 15, 2020028

Updated Date: Tue, 14 Jan 2020 00:00:00 EST Source link...

Latest News

STAT Plus: As families in Europe clamor for its pricey gene therapy, Novartis creates a lottery

NewsemiaDecember 22, 2019

by NewsemiaDecember 22, 201901

Seeking to provide its pricey gene therapy to patients in countries where the drug is not yet approved, Novartis (NVS) has taken the unusual step...

Latest News

Novartis eyes give-away of costly therapy for babies

NewsemiaDecember 21, 2019

by NewsemiaDecember 21, 201902

Swiss pharmaceutical company Novartis is preparing to give away 100 doses of the world’s most expensive drug, which treats a rare childhood disorder, but its...

Latest News

STAT Plus: Pharmalittle: Novartis plans a lottery for the world’s priciest drug; Trump importation could hit Gilead

NewsemiaDecember 19, 2019

by NewsemiaDecember 19, 201902

Rise and shine, everyone, another busy day is on the way. The holiday season may be fast approaching but there is still work to be...

Latest News

STAT Plus: Pharmalittle: Novartis to pay $9.7 billion for The Medicines Co.; Trump bashes Pelosi drug pricing bill

NewsemiaNovember 25, 2019

by NewsemiaNovember 25, 201902

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, Skype...

Latest News

Global Ophthalmology Therapeutics Market 2019-2023 | Evolving Opportunities with ALLERGAN and Novartis AG | Technavio

NewsemiaNovember 25, 2019

by NewsemiaNovember 25, 201903

LONDON–(BUSINESS WIRE)– #HealthcareDevices–Global ophthalmology therapeutics market is poised to grow by USD 9.6 billion during 2019-2023 at a CAGR of nearly 6% during the forecast...

Latest News

With $9.7 billion acquisition, Novartis bets that heart drugs are coming back

NewsemiaNovember 25, 2019

by NewsemiaNovember 25, 201903

Novartis’ $9.7 billion acquisition of The Medicines Company, which the companies announced Sunday after days of rumors, is a story of second acts. It represents...

Latest News

The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion

NewsemiaNovember 24, 2019

by NewsemiaNovember 24, 201901

PARSIPPANY, N.J.–(BUSINESS WIRE)—- $MDCO–The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines...

Latest News

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

NewsemiaNovember 13, 2019

by NewsemiaNovember 13, 201902

Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the...